JP6575031B2 - モンテルカストナトリウム製剤 - Google Patents

モンテルカストナトリウム製剤 Download PDF

Info

Publication number
JP6575031B2
JP6575031B2 JP2015159977A JP2015159977A JP6575031B2 JP 6575031 B2 JP6575031 B2 JP 6575031B2 JP 2015159977 A JP2015159977 A JP 2015159977A JP 2015159977 A JP2015159977 A JP 2015159977A JP 6575031 B2 JP6575031 B2 JP 6575031B2
Authority
JP
Japan
Prior art keywords
preparation
tablet
granulated product
coated
montelukast sodium
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Active
Application number
JP2015159977A
Other languages
English (en)
Japanese (ja)
Other versions
JP2016033133A (ja
JP2016033133A5 (https=
Inventor
貴光 龍野
貴光 龍野
翼 佐野
翼 佐野
絵美 高橋
絵美 高橋
英治 熊谷
英治 熊谷
康正 田代
康正 田代
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Nippon Chemiphar Co Ltd
Original Assignee
Nippon Chemiphar Co Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Nippon Chemiphar Co Ltd filed Critical Nippon Chemiphar Co Ltd
Priority to JP2015159977A priority Critical patent/JP6575031B2/ja
Publication of JP2016033133A publication Critical patent/JP2016033133A/ja
Publication of JP2016033133A5 publication Critical patent/JP2016033133A5/ja
Application granted granted Critical
Publication of JP6575031B2 publication Critical patent/JP6575031B2/ja
Active legal-status Critical Current
Anticipated expiration legal-status Critical

Links

Landscapes

  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicinal Preparation (AREA)
  • Medical Preparation Storing Or Oral Administration Devices (AREA)
JP2015159977A 2014-07-28 2015-07-28 モンテルカストナトリウム製剤 Active JP6575031B2 (ja)

Priority Applications (1)

Application Number Priority Date Filing Date Title
JP2015159977A JP6575031B2 (ja) 2014-07-28 2015-07-28 モンテルカストナトリウム製剤

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
JP2014153305 2014-07-28
JP2014153305 2014-07-28
JP2015159977A JP6575031B2 (ja) 2014-07-28 2015-07-28 モンテルカストナトリウム製剤

Related Child Applications (1)

Application Number Title Priority Date Filing Date
JP2019122670A Division JP7093752B2 (ja) 2014-07-28 2019-07-01 モンテルカストナトリウム製剤

Publications (3)

Publication Number Publication Date
JP2016033133A JP2016033133A (ja) 2016-03-10
JP2016033133A5 JP2016033133A5 (https=) 2018-08-02
JP6575031B2 true JP6575031B2 (ja) 2019-09-18

Family

ID=55452210

Family Applications (2)

Application Number Title Priority Date Filing Date
JP2015159977A Active JP6575031B2 (ja) 2014-07-28 2015-07-28 モンテルカストナトリウム製剤
JP2019122670A Active JP7093752B2 (ja) 2014-07-28 2019-07-01 モンテルカストナトリウム製剤

Family Applications After (1)

Application Number Title Priority Date Filing Date
JP2019122670A Active JP7093752B2 (ja) 2014-07-28 2019-07-01 モンテルカストナトリウム製剤

Country Status (1)

Country Link
JP (2) JP6575031B2 (https=)

Families Citing this family (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP2017001989A (ja) * 2015-06-11 2017-01-05 ニプロ株式会社 医薬組成物の製造方法及び医薬組成物
CN108057021B (zh) * 2017-12-25 2019-03-19 南京康舟医药科技有限公司 一种孟鲁斯特钠颗粒剂及其制备方法
WO2020111089A1 (ja) * 2018-11-27 2020-06-04 協和キリン株式会社 医薬組成物
CN112386578B (zh) * 2020-10-26 2022-11-22 石药集团欧意药业有限公司 一种孟鲁司特钠咀嚼片及其制备方法

Family Cites Families (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20090124657A1 (en) * 2007-08-14 2009-05-14 Ramesh Kappala Pharmaceutical compositions comprising montelukast
WO2009153305A2 (en) * 2008-06-19 2009-12-23 Sandoz Ag Pharmaceutical compositions of montelukast sodium
WO2010041277A2 (en) * 2008-10-06 2010-04-15 Jubilant Organosys Limited Stable pharmaceutical compositions of montelukast or its salts or solvates or hydrates
KR20130009553A (ko) * 2011-07-15 2013-01-23 한미약품 주식회사 몬테루카스트 또는 이의 약학적으로 허용가능한 염 및 레보세티리진 또는 이의 약학적으로 허용가능한 염을 함유하는 캡슐 제제
KR101418404B1 (ko) * 2012-01-06 2014-07-10 한미약품 주식회사 레보세티리진 또는 이의 약학적으로 허용가능한 염 및 몬테루카스트 또는 이의 약학적으로 허용가능한 염을 함유하는 안정한 경구투여용 약학 제제
CN103239450B (zh) * 2012-02-07 2014-11-26 齐鲁制药有限公司 一种能快速溶出、稳定的孟鲁司特钠口服固体制剂及其制备方法
JP5858486B2 (ja) * 2012-05-11 2016-02-10 塩野義製薬株式会社 アスコルビン酸、スクラロースおよびアスパルテームを含有する固形製剤
CN103494785B (zh) * 2013-10-09 2015-03-11 福建华海药业有限公司 一种孟鲁司特钠咀嚼片及其制备方法

Also Published As

Publication number Publication date
JP2016033133A (ja) 2016-03-10
JP2019156857A (ja) 2019-09-19
JP7093752B2 (ja) 2022-06-30

Similar Documents

Publication Publication Date Title
JP7093752B2 (ja) モンテルカストナトリウム製剤
JP5365777B2 (ja) 光に対して安定なラモセトロンの固形医薬組成物
JP6183979B2 (ja) アリピプラゾール無水物を含有する固形製剤の製造方法
TW202313027A (zh) 樂伐替尼（Ｌｅｎｖａｔｉｎｉｂ）調配物
AU2006213439A1 (en) Pharmaceutical composition of acid labile substances
TW201717937A (zh) 含有芳基烷基胺化合物之醫藥組合物
JP5270798B1 (ja) アゾセミドを有効成分とするコーティング製剤
WO2020111089A1 (ja) 医薬組成物
WO2015069203A1 (en) Capsule comprising rupatadine fumarate and montelukast sodium
JP4874797B2 (ja) フィルムコーティング錠
WO2005099698A1 (ja) 安定化された４－アミノ－５－クロロ－Ｎ－［（１Ｒ，３ｒ，５Ｓ）－８－メチル－８－アザビシクロ［３．２．１］オクタ－３－イル]－２－［１－メチルブタ－２－インイルオキシ］ベンズアミド含有組成物
JP7515533B2 (ja) デスロラタジン含有フィルムコーティング錠剤
JP2020029447A (ja) 腸溶性高分子及び抗付着剤を含有する顆粒
JP6133073B2 (ja) ループ利尿薬を有効成分とする医薬製剤
EP3251669B1 (en) Solid composition of pyrrole carboxamide
JP6336651B1 (ja) 化学的安定性が改善されたエソメプラゾール塩を含有する錠剤
JP6339800B2 (ja) ミグリトール含有コーティング製剤
JP2020066634A (ja) 腸溶性高分子及び崩壊剤を含有する顆粒
BRPI0621739A2 (pt) formulação estável que consiste em drogas sensìveis à umectação e seu procedimento de fabricação
JP2025073688A (ja) ボスチニブ医薬製剤
JP2022024813A (ja) アキシチニブ（ｉｖ型）を有効成分とする医薬錠剤及び包装された医薬錠剤
HK1247826B (en) Solid composition of pyrrole carboxamide
TR201719919A2 (tr) The pharmaceutical combination comprising raloxifene and aripiprazole
HK1179534B (en) Coated preparation containing azosemide as active ingredient
JP2012041290A (ja) ラフチジン含有固形製剤

Legal Events

Date Code Title Description
AA64 Notification of invalidation of claim of internal priority (with term)

Free format text: JAPANESE INTERMEDIATE CODE: A241764

Effective date: 20150908

A521 Request for written amendment filed

Free format text: JAPANESE INTERMEDIATE CODE: A523

Effective date: 20150911

A521 Request for written amendment filed

Free format text: JAPANESE INTERMEDIATE CODE: A523

Effective date: 20180620

A621 Written request for application examination

Free format text: JAPANESE INTERMEDIATE CODE: A621

Effective date: 20180620

A977 Report on retrieval

Free format text: JAPANESE INTERMEDIATE CODE: A971007

Effective date: 20190227

A131 Notification of reasons for refusal

Free format text: JAPANESE INTERMEDIATE CODE: A131

Effective date: 20190305

A521 Request for written amendment filed

Free format text: JAPANESE INTERMEDIATE CODE: A523

Effective date: 20190426

TRDD Decision of grant or rejection written
A01 Written decision to grant a patent or to grant a registration (utility model)

Free format text: JAPANESE INTERMEDIATE CODE: A01

Effective date: 20190604

A61 First payment of annual fees (during grant procedure)

Free format text: JAPANESE INTERMEDIATE CODE: A61

Effective date: 20190701

A61 First payment of annual fees (during grant procedure)

Free format text: JAPANESE INTERMEDIATE CODE: A61

Effective date: 20190731

R150 Certificate of patent or registration of utility model

Ref document number: 6575031

Country of ref document: JP

Free format text: JAPANESE INTERMEDIATE CODE: R150

R150 Certificate of patent or registration of utility model

Ref document number: 6575031

Country of ref document: JP

Free format text: JAPANESE INTERMEDIATE CODE: R150

R250 Receipt of annual fees

Free format text: JAPANESE INTERMEDIATE CODE: R250

R250 Receipt of annual fees

Free format text: JAPANESE INTERMEDIATE CODE: R250

R250 Receipt of annual fees

Free format text: JAPANESE INTERMEDIATE CODE: R250

R250 Receipt of annual fees

Free format text: JAPANESE INTERMEDIATE CODE: R250